| Drug General Information |
| Drug ID |
D0N0HK
|
| Former ID |
DNC005437
|
| Drug Name |
3,4,5,6-Tetrachloro-[1,2]benzoquinone
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Investigative |
[1]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C6Cl4O2
|
| Canonical SMILES |
C1(=C(C(=O)C(=O)C(=C1Cl)Cl)Cl)Cl
|
| InChI |
1S/C6Cl4O2/c7-1-2(8)4(10)6(12)5(11)3(1)9
|
| InChIKey |
VRGCYEIGVVTZCC-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| Target and Pathway |
| Target(s) |
Cholinesterase |
Target Info |
Inhibitor |
[1]
|
|---|
| Acetylcholinesterase |
Target Info |
Inhibitor |
[1]
|
| Liver carboxylesterase |
Target Info |
Inhibitor |
[1]
|
|
KEGG Pathway
|
Glycerophospholipid metabolism
|
|
Cholinergic synapsehsa00983:Drug metabolism - other enzymes
|
|
Metabolic pathways
|
|
PANTHER Pathway
|
Muscarinic acetylcholine receptor 1 and 3 signaling pathway
|
|
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
|
|
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway
|
|
Nicotinic acetylcholine receptor signaling pathway
|
|
Pathway Interaction Database
|
ATF-2 transcription factor networke2f_pathway:E2F transcription factor network
|
|
PathWhiz Pathway
|
Phospholipid Biosynthesis
|
|
WikiPathways
|
Irinotecan PathwayWP727:Monoamine Transport
|
|
Biogenic Amine Synthesis
|
|
Acetylcholine Synthesis
|
|
Integrated Pancreatic Cancer PathwayWP2884:NRF2 pathway
|
|
Nuclear Receptors Meta-Pathway
|
|
Heroin metabolism
|
|
Irinotecan Pathway
|
|
Fluoropyrimidine Activity
|
|
Phase I biotransformations, non P450
|
| References |
| REF 1 | J Med Chem. 2005 Apr 21;48(8):2906-15.Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases. |
|---|
